Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update
Checkmate Pharmaceuticals Inc.CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical...